NEW YORK, May 21, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of BlissCo Cannabis Corp. (Other OTC: HSTRF) on behalf of BlissCo shareholders concerning the proposed acquisition of the company by The Supreme Cannabis Company, Inc. (Other OTC: SPRWF).
Click here to participate in the action.
Pursuant to the proposed transaction, announced on May 16, 2019 and valued at $48 million, BlissCo shareholders will receive 0.24 shares of Supreme for each share of BlissCo common stock owned. The investigation focuses on whether BlissCo and its board of directors violated the federal securities laws and/or breached their fiduciary duties to the Company’s shareholders by failing to conduct a fair process and whether and by how much the proposed transaction undervalues the Company.
If you own BlissCo shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at firstname.lastname@example.org, or telephone at (212) 308-1869, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation of BlissCo please go to https://bespc.com/hstrf/. For additional information about Bragar Eagel & Squire, P.C. please go to www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.